We are live on ! Find out more
OLA

Oliver Luxxe Assets Portfolio holdings

AUM $680M
1-Year Est. Return 47.51%
This Fund
S&P 500
This Quarter Est. Return
+0.23%
1 Year Est. Return
+47.51%
3 Year Est. Return
+141.35%
5 Year Est. Return
+220.75%
10 Year Est. Return
+625.72%
AUM
$395M
AUM Growth
+$211K
Cap. Flow
+$9.86M
Cap. Flow %
2.5%
Top 10 Hldgs %
21.55%
Holding
226
New
31
Increased
81
Reduced
53
Closed
36

Top Buys

Rank Stock Value
1
BKR icon
Baker Hughes
BKR
+$5.7M
2
PG icon
Procter & Gamble
PG
+$4.59M
3
BDX icon
Becton Dickinson
BDX
+$4.44M
4
MCK icon
McKesson
MCK
+$4.33M
5
WBA
Walgreens Boots Alliance
WBA
+$4.3M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$4.63M
2
LRCX icon
Lam Research
LRCX
+$3.63M
3
BX icon
Blackstone
BX
+$3.35M
4
TJX icon
TJX Companies
TJX
+$3.3M
5
TEL icon
TE Connectivity
TEL
+$3.19M

Sector Composition

Rank Sector Weight
1 Industrials 16.84%
2 Financials 13.99%
3 Healthcare 12.69%
4 Energy 9.97%
5 Technology 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
F icon
201
Ford
F
$58B
– –
-150,134
Closed -$3.12M
FIX icon
202
Comfort Systems
FIX
$61.8B
– –
-6,663
Closed -$659K
IQV icon
203
IQVIA
IQV
$38.3B
– –
-6,499
Closed -$1.83M
KFY icon
204
Korn Ferry
KFY
$4.23B
– –
-7,767
Closed -$588K
KLIC icon
205
Kulicke & Soffa
KLIC
$4.67B
– –
-8,513
Closed -$515K
LH icon
206
Labcorp
LH
$25.1B
– –
-8,858
Closed -$2.39M
LRCX icon
207
Lam Research
LRCX
$366B
– –
-50,520
Closed -$3.63M
MA icon
208
Mastercard
MA
$501B
– –
-892
Closed -$320K
NXPI icon
209
NXP Semiconductors
NXPI
$55.7B
– –
-7,137
Closed -$1.63M
OMF icon
210
OneMain Financial
OMF
$7.41B
– –
-11,082
Closed -$555K
PRGS icon
211
Progress Software
PRGS
$1.72B
– –
-10,979
Closed -$530K
PVH icon
212
PVH
PVH
$4.04B
– –
-21,972
Closed -$2.34M
REGN icon
213
Regeneron Pharmaceuticals
REGN
$78.7B
– –
-7,337
Closed -$4.63M
SYNA icon
214
Synaptics
SYNA
$4.15B
– –
-1,467
Closed -$425K
TEL icon
215
TE Connectivity
TEL
$58.3B
– –
-19,801
Closed -$3.19M
TJX icon
216
TJX Companies
TJX
$173B
– –
-43,450
Closed -$3.3M
TNET icon
217
TriNet
TNET
$3.25B
– –
-3,452
Closed -$329K
VREX icon
218
Varex Imaging
VREX
$496M
– –
-11,584
Closed -$365K
XAR icon
219
State Street SPDR S&P Aerospace & Defense ETF
XAR
$6.12B
– –
-2,431
Closed -$283K
XPO icon
220
XPO
XPO
$23.2B
– –
-27,100
Closed -$1.25M
ZBRA icon
221
Zebra Technologies
ZBRA
$13.9B
– –
-2,884
Closed -$1.72M
ZD icon
222
Ziff Davis
ZD
$2B
– –
-3,801
Closed -$421K
ZTS icon
223
Zoetis
ZTS
$32.5B
– –
-1,266
Closed -$309K
SYNH
224
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-3,406
Closed -$350K
SJI
225
DELISTED
South Jersey Industries, Inc.
SJI
– –
-24,775
Closed -$647K
6 7 8
9
10

Similar funds

CCG
Clearlake Capital Group Santa Monica, California $680M AUM 30.34% 1-Year Est. Return
CIA
Covington Investment Advisors Ligonier, Pennsylvania $680M AUM 28.91% 1-Year Est. Return
NS
Night Squared New York $681M AUM 50% 1-Year Est. Return
AP
Advisors Preferred Rockville, Maryland $679M AUM 22.19% 1-Year Est. Return
DMC
Drexel Morgan & Co Radnor, Pennsylvania $682M AUM 21.01% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
REAM
Ripple Effect Asset Management New York $679M AUM 81.6% 1-Year Est. Return
HWM
Horizon Wealth Management La Grange, Illinois $682M AUM 25.04% 1-Year Est. Return

Oliver Luxxe Assets's Q1 2022 Portfolio in Review

As of Q1 2022, Oliver Luxxe Assets held 226 positions worth $395M, up 0.05% from $395M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Oliver Luxxe Assets's Q1 2022 filing shows 31 new, 81 increased, 53 reduced and 36 closed positions. Its largest new stake was Baker Hughes: 187,612 shares worth $6.83M. The largest sale was Regeneron Pharmaceuticals, an estimated $4.63M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oliver Luxxe Assets's largest Q1 2022 buy was Baker Hughes: 187,612 shares worth $6.83M.
  • Oliver Luxxe Assets added most to Procter & Gamble in Q1 2022, an estimated $4.59M increase.
  • Oliver Luxxe Assets's biggest Q1 2022 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $2.03M.
  • Oliver Luxxe Assets fully exited Regeneron Pharmaceuticals in Q1 2022, selling an estimated $4.63M.
  • Oliver Luxxe Assets's ten largest holdings make up 22% of its $395M portfolio in Q1 2022.
  • Oliver Luxxe Assets opened 31 new positions and closed 36 in Q1 2022.
  • Oliver Luxxe Assets's portfolio value rose 0.05% quarter-over-quarter to $395M.

Based on Oliver Luxxe Assets's 13F filing for Q1 2022, filed 13 May 2022.